Zobrazeno 1 - 10
of 294
pro vyhledávání: '"I. Mulder"'
Publikováno v:
Biogeosciences, Vol 9, Iss 3, Pp 1225-1235 (2012)
Due to their negative water budget most recent semi-/arid regions are characterized by vast evaporates (salt lakes and salty soils). We recently identified those hyper-saline environments as additional sources for a multitude of volatile halogenated
Externí odkaz:
https://doaj.org/article/d873b15d4c82496299a94ed251575e8e
Autor:
I. Mulder
Publikováno v:
Journal of Lipid Research, Vol 13, Iss 4, Pp 552-554 (1972)
Spectrophotometric determinations of acetyl CoA with malate dehydrogenase and citrate synthase are likely to overestimate the amount of acetyl CoA in solutions containing acetoacetyl CoA, since commercial preparations of malate dehydrogenase may cont
Externí odkaz:
https://doaj.org/article/2e0eabb07af14f4bb820f04719790186
Autor:
Frits I. Mulder, Nick van Es
Publikováno v:
HemaSphere, Vol 2, Pp 37-39 (2018)
Externí odkaz:
https://doaj.org/article/a169c05ced6745068f63b06cf7730c30
Autor:
Frits I. Mulder, Matteo Candeloro, Pieter W. Kamphuisen, Marcello Di Nisio, Patrick M. Bossuyt, Noori Guman, Kirsten Smit, Harry R. Büller, Nick van Es
Publikováno v:
Haematologica, Vol 104, Iss 6 (2019)
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were searched from January 2008 to June 2018 for studies which evaluated the Khorana score. Two aut
Externí odkaz:
https://doaj.org/article/d4493cafff344f108fe9e1dadfc67536
Autor:
Erzsébet Horváth-Puhó, H.W.M. van Laarhoven, Florian Moik, Henrik Toft Sørensen, Lisbeth Nørum Pedersen, H. R. Büller, N. van Es, Cihan Ay, Frits I. Mulder
Publikováno v:
Mulder, F I, Horváth-Puhó, E, van Es, N, van Laarhoven, H W M, Pedersen, L, Moik, F, Ay, C, Büller, H R & Sørensen, H T 2021, ' Venous thromboembolism in cancer patients : a population-based cohort study ', Blood, vol. 137, no. 14, pp. 1959-1969 . https://doi.org/10.1182/blood.2020007338
Blood, 137(14), 1959-1969. American Society of Hematology
Blood, 137(14), 1959-1969. American Society of Hematology
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in the past decade, possibly due to novel cancer therapies, improved survival, and high-resolution imaging. Danish medical registries were used to identify 499 092 pati
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nick van Es, Saskia Middeldorp, Floris T. M. Bosch, Pieter Willem Kamphuisen, Patrick M.M. Bossuyt, Frits I. Mulder, Harry R. Büller
Publikováno v:
Blood Adv
Guidelines suggest thromboprophylaxis for ambulatory cancer patients starting chemotherapy with an intermediate to high risk of venous thromboembolism (VTE) according to Khorana score. Data on thromboprophylaxis efficacy in different Khorana score ri
Autor:
Marc Carrier, Floris T. M. Bosch, Annie M. Young, Tyler Zemla, Harry R. Büller, Robert D. McBane, Patrick M.M. Bossuyt, Nick van Es, Frits I. Mulder, Andrea Marshall, Jeffrey I. Weitz, Pieter Willem Kamphuisen, Saskia Middeldorp
Publikováno v:
Blood. 136:1433-1441
Direct oral anticoagulants (DOACs) are an emerging treatment option for patients with cancer and acute venous thromboembolism (VTE), but studies have reported inconsistent results. This systematic review and meta-analysis compared the efficacy and sa
Autor:
H. R. Büller, Annelise Segers, Michele Mercuri, Peter Verhamme, Anil Duggal, Noémie Kraaijpoel, J. I. Weitz, Manila Gaddh, Sudeep Shivakumar, N. van Es, Michael A. Grosso, Marc Carrier, Tzu-Fei Wang, Gordon Royle, M. Di Nisio, Ajay K. Kakkar, George Zhang, Frits I. Mulder, David A. Garcia, Saskia Middeldorp, Gary E. Raskob
Publikováno v:
Thrombosis research, 185, 13-19. Elsevier Limited
Background The safety and efficacy of edoxaban and dalteparin is unclear for several cancer groups. Methods We evaluated the occurrence of the primary outcome in large cancer groups. The primary outcome was the composite of recurrent VTE or major ble
Autor:
Pieter Willem Kamphuisen, Ranjeeta Mallick, Marc Carrier, Phill S Wells, Nick van Es, Frits I. Mulder, Saskia Middeldorp, Floris T. M. Bosch
Publikováno v:
Journal of Thrombosis and Haemostasis, 20, 138-144
Journal of Thrombosis and Haemostasis, 20, 1, pp. 138-144
Journal of thrombosis and haemostasis, 20(1), 138-144. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20, 1, pp. 138-144
Journal of thrombosis and haemostasis, 20(1), 138-144. Wiley-Blackwell
Contains fulltext : 248717.pdf (Publisher’s version ) (Open Access) BACKGROUND: Growth differentiation factor-15 (GDF-15) is a strong predictor for bleeding in patients with atrial fibrillation, but there are no data on cardiovascular outcomes for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a08108025e4b86ac55dd05fd07d1a1
http://hdl.handle.net/2066/248717
http://hdl.handle.net/2066/248717